Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
84.22
-0.42 (-0.50%)
Dec 20, 2024, 4:00 PM EST - Market closed

Nuvalent Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
92
Market Cap
5.98B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.81B
Bausch + Lomb 4.68B
Elanco Animal Health 4.45B
Lantheus Holdings 1.50B
Merit Medical Systems 1.33B
Halozyme Therapeutics 947.36M
Waystar Holding 906.14M
Legend Biotech 520.18M
Revenue Rankings